Anbijie

Chongqing Anbijie Technology Joint-stock Co., Ltd. was established in 2006 and settled in the Beibei Technology Business Incubation Park of Chongqing High-tech Entrepreneurship Center. It has now developed into a joint-stock enterprise with registered capital of 21 million yuan and total assets of over 100 million yuan, a *high-tech enterprise, a listed enterprise on the Chongqing Equity Exchange Center, and a listed enterprise on the National Equities Exchange and Quotations (New Third Board). It is also a standing council member unit of the Chongqing Medical Device Industry Association and a council member unit of the Chongqing Bioengineering Society. Anbijie has a first-class scientific research, management team and laboratory, and has established long-term stable cooperative relations with many famous domestic universities, research institutions, and many overseas scientists. Relying on a strong scientific research team, it is committed to the development of the medical and health industry, creating core competitiveness in the field of new medical services, focusing on the development of new digital medical technologies, the application of digital medical technologies and remote transmission and application of medical technologies, as well as genetic diagnosis technology and ultrasound microbubble application in diagnosis and treatment technology, and has successfully launched technologies and series of products with intellectual property rights.
In 2006, Anbijie Technology Joint-stock Co., Ltd. took the lead in launching the patented product Anbijie brand disinfectant medical ultrasound coupling agent (trade name: Anxinchao) on the market, which solved the problem of disinfection of skin, mucous membranes, and ultrasound probes that had plagued the domestic medical ultrasound field, effectively blocked potential hospital cross-infection pathways, and opened up a brand-new market for disinfectant medical ultrasound coupling agents. After 10 years of market promotion and cultivation, this advanced concept of ours has been widely recognized and accepted by experts, scholars, and primary-level medical workers in the medical ultrasound field.
As of today, Anbijie products have obtained four Chongqing key new product titles and one high-tech product title; obtained 3 invention patents, 7 utility model patents, 1 design patent, 8 software copyrights, and introduced 2 patents.
Focus achieves professionalism. In the course of development, Anbijie completed the GMP transformation of its production workshop and implemented standardized management processes for product production in accordance with ISO13485 "Quality Management System for Medical Devices." At the same time, it has established long-term stable cooperative relations with many famous domestic universities, scientific research institutions, and senior overseas research scientists, reserving strength for the birth of many new technologies and new projects with high technical content that are leading domestically and synchronized with world standards.
The Anbijie Tongliang Industrial Park, covering an area of 66,700 ㎡, is about to be fully completed, and the Anbijie medical ultrasound coupling agent production workshop will also be built fully in accordance with the standards of EU CE certification. In November 2015, Anbijie completed the entire production relocation work, and the company's product production has become more standardized, and production capacity has also been greatly improved.
In addition, our company is a listed enterprise on the Chongqing Equity Exchange Center, with share name: Anbijie, and share code: 750007. On September 7, 2015, Anbijie submitted listing application materials to the National Equities Exchange and Quotations (New Third Board), and on November 17, 2015, it officially landed on the National Equities Exchange and Quotations (New Third Board) and was successfully listed, with stock name: Anbijie, and stock code: 834324.